Inhibition of substance P signaling aggravates the bone loss in ovariectomy-induced osteoporosis

被引:17
|
作者
Zheng, Xin-Feng [1 ]
Zhao, En-Dian [1 ]
He, Ji-Ye [1 ]
Zhang, Yue-Hui [1 ]
Jiang, Sheng-Dan [1 ]
Jiang, Lei-Sheng [1 ]
机构
[1] Shanghai Jiao Tong Univ, Xinhua Hosp, Sch Med, Dept Orthopaed Surg, 1665 Kongjiang Rd, Shanghai 200092, Peoples R China
来源
关键词
Osteoporosis; Substance P; NK1; receptor; Bone remodeling; Ovariectomy; VASOACTIVE-INTESTINAL-PEPTIDE; RECEPTOR NK1 ANTAGONIST; GENE-RELATED PEPTIDE; SPINAL-CORD-INJURY; NEUROKININ-1; RECEPTOR; REPRODUCTIVE FUNCTION; PARATHYROID-HORMONE; ESTROGEN; CELLS; RAT;
D O I
10.1016/j.pbiomolbio.2016.05.011
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Introduction: Substance P signaling regulates the functions of both osteoblast and osteoclast. Available reports on the effects of substance P on bone mass are contradictory. The objective of this study was to determine the change of substance P expression in the osteoporotic bone of OVX mice. The effects of substance P signaling blockade by using its specific receptor antagonist L-703606 on bone remodeling in sham-operated mice and OVX mice were also investigated. Methods: Forty-eight nine-week-old female C57BL/6J mice were evenly distributed into three groups with sham surgery, OVX or OVX with estrogen replacement. Substance P expression in the bones of each group of mice was evaluated by immunohistochemistry and enzyme immunoassay. Another thirty-two nine-week-old female C57BL/6J mice were divided into a SHAM group (sham surgery followed by vehicle treatment with DMSO), a SHAM + L group (sham surgery followed by 15 mg/kg/d L-703606 repeated intraperitoneal injections), an OVX group (ovariectomy with the same vehicle treatment) and an OVX + L group (ovariectomy with the same L-703606 injections), with 8 mice in each group. Treatment started 3 weeks after surgery and last for 3 weeks. A 2 x 2 factorial experimental design was used to detect the effects of substance P signaling blockade on bone remodeling in sham-operated mice and OVX mice. Techniques including micro-computed tomography, biomechanical testing, histomorphometric analysis, enzyme immunoassay, and real-time PCR were employed. Results: Immunohistochemistry and enzyme immunoassay revealed that substance P expression significantly decreased in the bones of OVX mice both at 3 weeks and 6 weeks after surgery. Micro-CT tomography demonstrated that application of L-703606 led to bone loss in sham-operated mice, and aggravated the micro-structural deterioration of bones in OVX mice. This was shown by reduced BV/TV (Mean bone volume fraction), Tb.N (Mean trabecular number) and Tb.Th (Mean trabecular thickness), and increased Tb.Sp (Mean trabecular separation). Biomechanical analysis demonstrated that blockade of substance P signaling reduced the maximum stress and maximum load of L3 vertebrae and tibiae. Inhibited recruitment of bone mesenchymal stem cells (BMSCs) to bone remodeling sites, which was evidenced by increased number of osteoclasts, decreased number of osteoblasts and increased osteoid volume in the secondary spongiosa, was observed in the mice treated with L-703606. A significant decrease of OPG/RANKL ratio was also found in the bones of mice treated with L-703606. Body weight, uterine weight and serum estradiol level were not significantly different between the mice treated with L-703606 and those treated with vehicle. Conclusion: The results demonstrated that blocking substance P signaling led to bone loss in sham operated mice, and exacerbated the bone loss in OVX mice. Substance P signaling had an important role in the maintenance of bone mass. (C) 2016 Elsevier Ltd. All rights reserved.
引用
收藏
页码:112 / 121
页数:10
相关论文
共 50 条
  • [21] Influence of kaempferol on bone mineral density in rats with ovariectomy-induced osteoporosis
    Nowak, Beata
    Matuszewska, Agnieszka
    Dziewiszek, Wojciech
    Jedrzejuk, Diana
    Sadanowicz, Ewa
    Landwojtowicz, Marcin
    Piasecki, Tomasz
    Szandruk, Marta
    Merwid-Lad, Anna
    Trocha, Malgorzata
    Kwiatkowska, Joanna
    Szelag, Adam
    PHARMACOLOGICAL REPORTS, 2015, 67 : 31 - 31
  • [22] Anti-osteoporosis activity of red yeast rice extract on ovariectomy-induced bone loss in rats
    Wang, Y. F.
    Liu, W. T.
    Chen, C. Y.
    Ke, H. P.
    Jiang, H. L.
    Chen, X. L.
    Shi, S. Y.
    Wei, W.
    Zhang, X. N.
    GENETICS AND MOLECULAR RESEARCH, 2015, 14 (03) : 8137 - 8146
  • [23] Amlexanox Suppresses Osteoclastogenesis and Prevents Ovariectomy-Induced Bone Loss
    Yong Zhang
    Hanfeng Guan
    Jing Li
    Zhong Fang
    Wenjian Chen
    Feng Li
    Scientific Reports, 5
  • [24] Epoxyeicosanoids suppress osteoclastogenesis and prevent ovariectomy-induced bone loss
    Guan, Hanfeng
    Zhao, Libo
    Cao, Huijuan
    Chen, Anmin
    Xiao, Jun
    FASEB JOURNAL, 2015, 29 (03): : 1092 - 1101
  • [25] Protective Effect of Pycnogenol® on Ovariectomy-induced Bone Loss in Rats
    Mei, Lin
    Mochizuki, Miyako
    Hasegawa, Noboru
    PHYTOTHERAPY RESEARCH, 2012, 26 (01) : 153 - 155
  • [26] Thiazolidinediones, but not sitagliptin, exacerbate ovariectomy-induced bone loss in rats
    Cusick, T.
    Mu, J.
    Pennypacker, B.
    Li, Z.
    Lu, K.
    Glantschnig, H.
    Johnson, C.
    Shen, X.
    Kimmel, D. B.
    Thornberry, N. A.
    Zhang, B. B.
    DIABETOLOGIA, 2009, 52 : S336 - S336
  • [27] TIANEPTINE AMELIORATES OVARIECTOMY-INDUCED BONE LOSS IN WISTAR RATS
    Abuohashish, Hatem M.
    Al-Rejaie, Salim S.
    OSTEOPOROSIS INTERNATIONAL, 2012, 23 : S368 - S368
  • [28] BORTEZOMIB INHIBITS OSTEOCLASTOGENESIS AND OVARIECTOMY-INDUCED BONE LOSS IN MICE
    Lee, Y.
    Kim, Y. -G
    Choi, S. -Y
    OSTEOPOROSIS INTERNATIONAL, 2018, 29 : S477 - S477
  • [29] HA15 alleviates bone loss in ovariectomy-induced osteoporosis by targeting HSPA5
    Han, Chao
    Xie, Kegong
    Yang, Chengliang
    Zhang, Fan
    Liang, Qingyang
    Lan, Changgong
    Chen, Jian
    Huang, Ke
    Liu, Jia
    Li, Kai
    Tang, Yujin
    Wang, Liqiang
    EXPERIMENTAL CELL RESEARCH, 2021, 406 (02)
  • [30] Biglycan deficiency interferes with ovariectomy-induced bone loss.
    Nielsen, KL
    Allen, MR
    Bloomfield, SA
    Timm, IA
    Chen, XD
    Young, MF
    Heegaard, A
    JOURNAL OF BONE AND MINERAL RESEARCH, 2002, 17 : S170 - S170